Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RUBY

Rubius Therapeutics

$0.00

(0.00%)

10:43
07/18/18
07/18
10:43
07/18/18
10:43
Syndicate
Breaking Syndicate news story on Rubius Therapeutics »

Rubius Therapeutics opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

RUBY

Rubius Therapeutics

$0.00

(0.00%)

10:31
07/18/18
07/18
10:31
07/18/18
10:31
Syndicate
Breaking Syndicate news story on Rubius Therapeutics »

Rubius Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

RUBY

Rubius Therapeutics

$0.00

(0.00%)

10:21
07/18/18
07/18
10:21
07/18/18
10:21
Syndicate
Breaking Syndicate news story on Rubius Therapeutics »

Rubius Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

RUBY

Rubius Therapeutics

$0.00

(0.00%)

10:18
07/18/18
07/18
10:18
07/18/18
10:18
Syndicate
Rubius Therapeutics indicated to open at $29.90, IPO priced at $23.00 »

Rubius Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

RUBY

Rubius Therapeutics

$0.00

(0.00%)

06:38
07/18/18
07/18
06:38
07/18/18
06:38
Syndicate
Rubius Therapeutics 9.53M share IPO priced at $23.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.